Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Hill reported to Armour that two children had seroconverted to HIV following their use of Armour heat-treated Factorate.

  • Read more about Dr Hill reported to Armour that two children had seroconverted to HIV following their use of Armour heat-treated Factorate.

In a report prepared by Dr Franklin and Dr Hill, it was reported that 60% of the patients at BCH were positive for HIV.

  • Read more about In a report prepared by Dr Franklin and Dr Hill, it was reported that 60% of the patients at BCH were positive for HIV.

Dr Hill continued to screen children for HTLV-3 antibodies, that just over 50% were positive and that Dr Hill suspected that all children who have had a long exposure to concentrate may well have been infected.

  • Read more about Dr Hill continued to screen children for HTLV-3 antibodies, that just over 50% were positive and that Dr Hill suspected that all children who have had a long exposure to concentrate may well have been infected.

Armour made regular financial contributions to Dr Hill's "research fund".

  • Read more about Armour made regular financial contributions to Dr Hill's "research fund".

Armour had been the sole supplier of heat-treated Factor 8 to the region up to the point at which it was discovered that previously HIV negative children at Birmingham Children's Hospital treated with heated Factorate had been infected with HIV.

  • Read more about Armour had been the sole supplier of heat-treated Factor 8 to the region up to the point at which it was discovered that previously HIV negative children at Birmingham Children's Hospital treated with heated Factorate had been infected with HIV.

The commercial heat-treated Factor 8 product used at Birmingham Children's Hospital in 1985 and 1986 was Armour's product.

  • Read more about The commercial heat-treated Factor 8 product used at Birmingham Children's Hospital in 1985 and 1986 was Armour's product.

West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs supported the document prepared by the Reference Centres Directors on the effects of AIDS on the treatment of haemophiliacs.

  • Read more about West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs supported the document prepared by the Reference Centres Directors on the effects of AIDS on the treatment of haemophiliacs.

Dr Hill downplayed the risk of getting AIDS from using Factor VIII concentrate compared to the risk of arthritis by not using it.

  • Read more about Dr Hill downplayed the risk of getting AIDS from using Factor VIII concentrate compared to the risk of arthritis by not using it.

New Scientist published an article which referred to the possibility of AIDS being spread through Factor 8 concentrates.

  • Read more about New Scientist published an article which referred to the possibility of AIDS being spread through Factor 8 concentrates.

A report was produced by Professor Ingram, no evidence was found of any consideration being given to prioritising the child for NHS concentrate, or that consideration should have been given to no product in the place of commercial product.

  • Read more about A report was produced by Professor Ingram, no evidence was found of any consideration being given to prioritising the child for NHS concentrate, or that consideration should have been given to no product in the place of commercial product.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Current page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.